Large cohort studies have further demonstrated that CHIP is associated with an expansion of HPCs carrying recurrent somatic mutations which are common in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)24,25. Here, STUB1 is linked to acute myeloid leukemia.